Related Experiment Video
Updated: Oct 15, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.2K
The National Comprehensive Governance for epilepsy prevention and control in China
Shichuo Li1, Yuping Wang1,2, Wenzhi Wang3
1China Association Against Epilepsy, Beijing, China.
Epilepsia Open
|October 30, 2021
Summary
China
Area of Science:
- Neurology
- Public Health
- Healthcare Management
Background:
- Epilepsy poses a significant public health challenge globally.
- Effective national strategies are crucial for epilepsy prevention and control.
- China's approach offers a model for comprehensive epilepsy management.
Purpose of the Study:
- To describe China's national comprehensive governance program for epilepsy prevention and control.
- To highlight the key elements of this strategic national-level program.
- To provide insights into a multi-faceted approach to epilepsy management.
Main Methods:
- The article outlines a strategic working program for national epilepsy prevention and control.
- It details ten key elements integral to the comprehensive governance model.
- These elements encompass network development, community care, public awareness, data management, and research.
Main Results:
- China has implemented a national comprehensive governance program for epilepsy.
- The program integrates a multi-tiered network, community care, and public education.
- Key components include a big data platform, telemedicine, capacity building, research, partnerships, and international collaboration.
Conclusions:
- China's national epilepsy governance program serves as a strategic example for national-level epilepsy prevention and control.
- The program's success relies on a comprehensive, multi-element approach.
- This model emphasizes integrated care, research, and collaboration for improved epilepsy outcomes.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
359
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
359
01:20Antiepileptic Drugs: Potassium Channel Activators
351
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
351
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
802
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
802
01:30Electroconvulsive Therapy
260
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
260